SI
Price:
$15.12
Market Cap:
$311.50M
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Industry
Medical - Specialties
IPO Date
2025-07-31
Stock Exchange
NYSE
Ticker
SI
According to SHOULDER INNOVATIONS, INC.’s latest financial reports and current stock price. The company's current Current Ratio is 5.52. This represents a change of 28.21% compared to the average of 4.30 of the last 4 quarters.
The mean historical Current Ratio of SHOULDER INNOVATIONS, INC. over the last ten years is 7.88. The current 5.52 Current Ratio has changed 6.90% with respect to the historical average. Over the past ten years (40 quarters), SI's Current Ratio was at its highest in in the December 2023 quarter at 11.17. The Current Ratio was at its lowest in in the March 2023 quarter at 0.
Average
7.88
Median
7.88
Minimum
4.59
Maximum
11.17
Discovering the peaks and valleys of SHOULDER INNOVATIONS, INC. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Current Ratio = 11.17
Minimum Annual Increase = -58.88%
Minimum Annual Current Ratio = 4.59
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 4.59 | -58.88% |
The current Current Ratio of SHOULDER INNOVATIONS, INC. (SI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.88
5-year avg
7.88
10-year avg
7.88
SHOULDER INNOVATIONS, INC.’s Current Ratio is greater than Inogen, Inc. (3.14), greater than SANUWAVE Health, Inc. (1.16), greater than MDxHealth S.A. (1.14), less than Outset Medical, Inc. (7.09), less than Aardvark Therapeutics, Inc. Common Stock (12.03), greater than Nano-X Imaging Ltd. (4.19), less than Eupraxia Pharmaceuticals Inc. (8.72), greater than Assembly Biosciences, Inc. (1.64), greater than Enanta Pharmaceuticals, Inc. (4.21), less than Nautilus Biotechnology, Inc. (14.95),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.14 | $189.76M | |
| 1.16 | $290.63M | |
| 1.14 | $180.17M | |
| 7.09 | $85.68M | |
| 12.03 | $269.99M | |
| 4.19 | $244.21M | |
| 8.72 | $196.53M | |
| 1.64 | $303.71M | |
| 4.21 | $300.59M | |
| 14.95 | $261.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SHOULDER INNOVATIONS, INC. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SHOULDER INNOVATIONS, INC. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is SHOULDER INNOVATIONS, INC.'s Current Ratio?
How is the Current Ratio calculated for SHOULDER INNOVATIONS, INC. (SI)?
What is the highest Current Ratio for SHOULDER INNOVATIONS, INC. (SI)?
What is the 3-year average Current Ratio for SHOULDER INNOVATIONS, INC. (SI)?
What is the 5-year average Current Ratio for SHOULDER INNOVATIONS, INC. (SI)?
How does the current Current Ratio for SHOULDER INNOVATIONS, INC. (SI) compare to its historical average?